Placebo transdermal patch
Sponsors
National Institute on Aging (NIA), ZARS Pharma Inc., Purdue Pharma LP, The Cleveland Clinic, University of Colorado, Denver
Conditions
Age-Related Memory DisordersAgingBreast CancerChemo BrainChemo FogChemobrainChemotherapy-related Cognitive ImpairmentMenopause
Early Phase 1
Phase 1
Phase 2
Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee
CompletedNCT00108810
Start: 2005-04-30End: 2005-10-31Updated: 2012-06-05
Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study
CompletedNCT02312934
Start: 2015-08-31End: 2018-05-31Updated: 2020-01-21
Phase 3
Unknown Phase
Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients
TerminatedNCT01602198
Start: 2011-06-30End: 2013-01-31Updated: 2017-02-28
Tulobuterol Patch in Pediatric Patients Undergoing Tonsillectomy
CompletedNCT04057469
Start: 2019-12-20End: 2021-09-30Updated: 2022-01-14
Human Transdermal Vitamin D Supplement Study
CompletedNCT06098846
Start: 2023-10-23End: 2024-09-10Updated: 2025-08-12